tradingkey.logo
tradingkey.logo
Search

Corbus Pharmaceuticals Holdings Inc

CRBP
Add to Watchlist
7.400USD
-0.340-4.39%
Market hours 09/24, 13:45ET
137.12MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-4.39%

5 Days

+1.93%

1 Month

-28.71%

6 Months

-12.22%

Year to Date

-9.09%

1 Year

-35.88%

Key Figures

7.670Open
7.980High
40.85KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.22%Turnover Ratio
7.740Prev. Close
7.130Low
303.10KTurnover
LossP/E Static
1.34P/B
0.00%Div Yield TTM
-59.44%ROA
20.56052wk High
0.08Volume Ratio
-40.21MNet Profit
18.53MShares
-5.7339EPS TTM
2.59Beta
-66.70%ROE
6.32552wk Low
10.98%Amplitude
--Gross Margin
137.12MMarket Cap
3.12Reward/Risk
5.12%Risk Rate
More news coming soon, stay tuned...

Corbus Pharmaceuticals Holdings Inc's Score

-0.03vs previous score
Forecast9.00
Financial Health6.67
Technical5.97
Valuation Dimensions6.97
Institutional Confidence7.00
Risk Assessment4.34

Media Coverage

Coverage Level

Very Low
Very High
No data

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
Strong BuyCurrent Rating
35.889Target Price
+355.73%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy55555444
Buy55555666
Hold00000000
Sell00000000
Strong Sell00000000

Corbus Pharmaceuticals Holdings Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-1.81/-1.26
Revenue / Forecast
--/0.00

Corbus Pharmaceuticals Holdings Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolCRBP
Number of employees28
CountryUnited States of America

Ownership

ShareholdersProportion
Cormorant Asset Management, LP12.66%
OrbiMed Advisors, LLC8.62%
abrdn Inc.7.13%
Octagon Capital Advisors LP5.15%
Shareholder TypesProportion
Hedge Fund37.90%
Investment Advisor/Hedge Fund16.00%
Investment Advisor10.36%
Private Equity9.11%

FAQs

What is the current price of Corbus Pharmaceuticals Holdings Inc (CRBP)?

The current price of Corbus Pharmaceuticals Holdings Inc (CRBP) is 7.74.

What is the symbol of Corbus Pharmaceuticals Holdings Inc?

The ticker symbol of Corbus Pharmaceuticals Holdings Inc is CRBP.

What is the 52-week high of Corbus Pharmaceuticals Holdings Inc?

The 52-week high of Corbus Pharmaceuticals Holdings Inc is 20.56.

What is the 52-week low of Corbus Pharmaceuticals Holdings Inc?

The 52-week low of Corbus Pharmaceuticals Holdings Inc is 6.33.

What is the market capitalization of Corbus Pharmaceuticals Holdings Inc?

The market capitalization of Corbus Pharmaceuticals Holdings Inc is 143.42M.

Is Corbus Pharmaceuticals Holdings Inc (CRBP) currently rated as Buy, Hold, or Sell?

According to analysts, Corbus Pharmaceuticals Holdings Inc (CRBP) has an overall rating of STRONG BUY, with a price target of 35.89.

What is the Earnings Per Share (EPS TTM) of Corbus Pharmaceuticals Holdings Inc (CRBP)?

The Earnings Per Share (EPS TTM) of Corbus Pharmaceuticals Holdings Inc (CRBP) is -5.73.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.